71 West Capital Partners Buys New Holdings in Danaher Corporation $DHR

71 West Capital Partners bought a new stake in Danaher Corporation (NYSE:DHR) during the fourth quarter, HoldingsChannel reports. The fund bought 3,199 shares of the conglomerate’s stock, valued at approximately $732,000.

A number of other large investors have also recently bought and sold shares of the company. Bank Pictet & Cie Europe AG lifted its holdings in Danaher by 25.4% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock valued at $83,895,000 after acquiring an additional 74,301 shares during the period. Maxi Investments CY Ltd acquired a new position in Danaher in the third quarter valued at approximately $3,251,000. Defender Capital LLC. acquired a new position in Danaher in the fourth quarter valued at approximately $35,715,000. Northwestern Mutual Wealth Management Co. lifted its holdings in Danaher by 303.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after acquiring an additional 186,584 shares during the period. Finally, CIBC Bancorp USA Inc. acquired a new position in Danaher in the third quarter valued at approximately $17,480,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.5%

NYSE DHR opened at $181.04 on Tuesday. The business has a fifty day moving average price of $180.73 and a 200 day moving average price of $204.27. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The company has a market cap of $128.13 billion, a P/E ratio of 35.02, a P/E/G ratio of 2.30 and a beta of 0.81.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the company earned $1.88 EPS. The firm’s revenue was up 3.7% compared to the same quarter last year. Research analysts anticipate that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.

Analysts Set New Price Targets

A number of brokerages have issued reports on DHR. Citigroup began coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target for the company. Wells Fargo & Company decreased their price target on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a report on Wednesday, April 22nd. JPMorgan Chase & Co. decreased their price target on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Morgan Stanley decreased their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Finally, The Goldman Sachs Group decreased their price target on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.